116 related articles for article (PubMed ID: 16330377)
1. [Prognostic factors in chronic lymphocytic leukaemia: contribution of recent biological markers].
Evrard S; Gaussem P; Helley D; Darnige L
Ann Biol Clin (Paris); 2005; 63(6):589-97. PubMed ID: 16330377
[TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic leukemia: staging and prognostic factors.
Zwiebel JA; Cheson BD
Semin Oncol; 1998 Feb; 25(1):42-59. PubMed ID: 9482526
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukaemia.
Boelens J; Lust S; Vanhoecke B; Offner F
Anticancer Res; 2009 Feb; 29(2):605-15. PubMed ID: 19331210
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification in chronic lymphocytic leukemia.
Seiler T; Döhner H; Stilgenbauer S
Semin Oncol; 2006 Apr; 33(2):186-94. PubMed ID: 16616065
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
7. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
8. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
[TBL] [Abstract][Full Text] [Related]
9. Use of prognostic factors in risk stratification at diagnosis and time of treatment of patients with chronic lymphocytic leukemia.
Gowda A; Byrd JC
Curr Opin Hematol; 2006 Jul; 13(4):266-72. PubMed ID: 16755224
[TBL] [Abstract][Full Text] [Related]
10. RNA-based markers as prognostic factors in chronic lymphocytic leukemia.
Sevov M; Rosenquist R; Mansouri L
Expert Rev Hematol; 2012 Feb; 5(1):69-79. PubMed ID: 22272707
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and clinical staging in chronic lymphocytic leukemia.
Rai KR; Han T
Hematol Oncol Clin North Am; 1990 Apr; 4(2):447-56. PubMed ID: 2182601
[TBL] [Abstract][Full Text] [Related]
12. Prognostic markers in chronic lymphocytic leukaemia.
Hamblin TJ
Best Pract Res Clin Haematol; 2007 Sep; 20(3):455-68. PubMed ID: 17707833
[TBL] [Abstract][Full Text] [Related]
13. Treatment of B-cell chronic lymphocytic leukaemia: current status and future perspectives.
Montserrat E; Bosch F; Rozman C
J Intern Med Suppl; 1997; 740():63-7. PubMed ID: 9350185
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis of chronic lymphocytic leukemia: focus on recent biomarkers].
Véronèse L; Tchirkov A; Gouas L; Périssel B; Goumy C; Vago P
Ann Biol Clin (Paris); 2008; 66(4):371-7. PubMed ID: 18725337
[TBL] [Abstract][Full Text] [Related]
15. Chronic lymphocytic leukemia.
Ghia P; Ferreri AM; Caligaris-Cappio F
Crit Rev Oncol Hematol; 2007 Dec; 64(3):234-46. PubMed ID: 17544290
[TBL] [Abstract][Full Text] [Related]
16. Subclinical chronic lymphocytic leukaemia associated with a 13q deletion presenting initially in the skin: apropos of a case.
Khandelwal A; Seilstad KH; Magro CM
J Cutan Pathol; 2006 Mar; 33(3):256-9. PubMed ID: 16466516
[TBL] [Abstract][Full Text] [Related]
17. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.
Zenz T; Döhner H; Stilgenbauer S
Best Pract Res Clin Haematol; 2007 Sep; 20(3):439-53. PubMed ID: 17707832
[TBL] [Abstract][Full Text] [Related]
18. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
19. The use of molecular markers in selecting therapy for CLL.
Döhner H
Clin Adv Hematol Oncol; 2005 Feb; 3(2):103-4. PubMed ID: 16166976
[No Abstract] [Full Text] [Related]
20. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
